KEROS THERAPEUTICS IN
60.33
08-October-24 12:29:35
15 minutes delayed
Stocks
+0.21
+0.34%
Today's range
59.95 - 61.00
ISIN
N/A
Source
NASDAQ
-
Keros Therapeutics to Present at Upcoming Healthcare Conferences
07 Nov 2023 08:00:00 By Nasdaq GlobeNewswire
-
Keros Therapeutics Reports Recent Business Highlights and Third Quarter 2023 Financial Results
06 Nov 2023 08:00:01 By Nasdaq GlobeNewswire
-
02 Nov 2023 09:00:00 By Nasdaq GlobeNewswire
-
04 Oct 2023 08:00:00 By Nasdaq GlobeNewswire
-
Keros Therapeutics to Present at Upcoming Healthcare Conferences
05 Sep 2023 08:00:00 By Nasdaq GlobeNewswire
-
Keros Therapeutics Reports Recent Business Highlights and Second Quarter 2023 Financial Results
07 Aug 2023 08:00:00 By Nasdaq GlobeNewswire
-
12 Jun 2023 08:00:00 By Nasdaq GlobeNewswire
-
Keros Therapeutics to Present at Goldman Sach’s 44th Annual Global Healthcare Conference
07 Jun 2023 08:00:00 By Nasdaq GlobeNewswire
-
22 May 2023 09:00:00 By Nasdaq GlobeNewswire
-
Keros Therapeutics to Present at the 28th Annual Congress of the European Hematology Association
11 May 2023 16:01:01 By Nasdaq GlobeNewswire
-
Keros Therapeutics Reports Recent Business Highlights and First Quarter 2023 Financial Results
04 May 2023 16:01:00 By Nasdaq GlobeNewswire
-
Keros Therapeutics Appoints Alpna Seth, Ph.D., to its Board of Directors
19 Apr 2023 08:00:00 By Nasdaq GlobeNewswire
-
03 Mar 2023 16:01:00 By Nasdaq GlobeNewswire
-
Keros Therapeutics to Present at Cowen’s 43rd Annual Health Care Conference
01 Mar 2023 08:00:02 By Nasdaq GlobeNewswire
-
Keros Therapeutics to Present at the SVB Securities Global Biopharma Conference
07 Feb 2023 08:00:01 By Nasdaq GlobeNewswire
-
Keros Therapeutics to Present at Upcoming Healthcare Conferences
22 Nov 2022 08:00:01 By Nasdaq GlobeNewswire
-
07 Nov 2022 16:01:00 By Nasdaq GlobeNewswire